A recent systematic review of over 23,000 patients using anti-TNF therapy in the treatment of RA, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease, has further characterized infections associated with biologics. The gene discussed is TNF; the disease is infection.